Clinical trials
Phase 2 Lymphoma, Non-Hodgkin trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 2 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Active, not recruiting | 5 |
| Terminated | 5 |
| Recruiting | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 4 |
| Bayside Health | 3 |
| Incyte Corporation | 2 |
| AstraZeneca | 1 |
| Bayer | 1 |
| Bristol-Myers Squibb | 1 |
| Celgene | 1 |
| Celgene Corporation | 1 |
| Cellectar Biosciences, Inc. | 1 |
| Cephalon | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Non-Hodgkin | 24 |
| Lymphoma | 9 |
| Lymphoma, Large B-Cell, Diffuse | 6 |
| Recurrence | 5 |
| Ependymoma | 4 |
| Glioma | 4 |
| Hepatoblastoma | 4 |
| Histiocytosis, Langerhans-Cell | 4 |
| Lymphoma, Follicular | 4 |
| Medulloblastoma | 4 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.